The results from this study showed that the chimeric ADV efficiently reduced tumor size and that the expression levels of Rantes were elevated in the blood of mice treated with Ad5F11bSP-Rantes compared to a control and an eGFP expressing ADV. This evidence concerns the gene CCL5 and neoplasm.